Pancreatic Cancer Survival Rates

The pancreatic cancer survival rate is one of the worst of common cancers. Pancreatic cancer is one of the most feared diagnoses for good reason. Most people diagnosed with pancreatic cancer are no longer alive five years after diagnosis. For all stages of pancreatic cancer, the one-year relative survival is 28.8% and the five-year rate is 7.9%.

Pancreatic cancer is so deadly because it’s difficult to screen the pancreas for cancers and symptoms of pancreatic cancer are mild, so tumors there often get diagnosed late. About half of the pancreatic cancers have advanced to stage 4 when diagnosed—so they are very difficult to treat because they’ve metastasized (spread) to other organs.

The American Cancer Society predicted 57,600 pancreatic cancer diagnoses in 2020, and 47,050 deaths. It’s slightly more common in men than women, and it gets more common as you get older.

Rates of pancreatic cancer are higher for Black Americans are than for White Americans, and even lower in Asian Americans and Pacific Islanders. Pancreatic cancer prognosis is not good, though it varies by stage diagnosed and other factors.

Let’s walk through the survival rates for pancreatic cancer and get a better idea of what influences them. 

Pancreatic cancer purple ribbons


ThitareeSarmkasat / iStock / Getty Images

Pancreatic Cancer Stages

Doctors use cancer stages to describe how cancer has grown or spread. Cancer stages help researchers compare patients with similar diagnoses, track cancer progression, study the effectiveness of treatments, and estimate survival rates. Cancer’s classification system, called the TNM system, was developed by the American Joint Committee on Cancer.

The system has three components:

  • T for tumor: This is based on the tumor’s size.
  • N for lymph nodes: Lymph node involvement makes it easier for cancer to spread to other parts of the body. 
  • M for metastasis: Metastasis is the spread of cancer to distant organs and lymph nodes. 

Cancer’s stage will always be what it was when diagnosed, even if the patient improves or gets worse. When the doctor re-stages the cancer, or if it recurs, they keep the initial staging diagnosis and the doctor adds a new stage to the patient’s diagnosis.

While some doctors use the TNM staging system, others prefer to categorize pancreatic cancer into four buckets:

  • Resectable: Surgery can remove the tumor.
  • Borderline resectable: The tumor is difficult or impossible to remove but surgery might work after other treatments shrink the tumor. 
  • Locally advanced: Doctors can’t remove the tumor surgically because it has spread to areas around the pancreas. 
  • Metastatic: Cancer has spread beyond the area of the pancreas to other organs.

Another term that factors into cancer’s diagnosis, treatment, and staging is the tumor’s grade. Doctors will examine the cancerous cells and tissues taken from surgery or a biopsy in the lab and compare how they look to how normal cells look and give them a grade.

Cancer has three grades: grade 1 (low grade), grade 2 (intermediate grade), or grade 3 (high grade) based on how it looks. If a tumor is low-grade, its cells usually look pretty normal or well-differentiated, and they are typically slower-growing.

A high-grade tumor is likely to be more aggressive, look less like a normal cell, and spread quickly. Doctors call these undifferentiated or poorly differentiated tumor cells because they lack the features and structures of normal cells and tissues. Higher grade cancers are usually also higher stage.

Survival Rates

Survival rates help doctors estimate how long a person with a will survive based on the diagnosis given. The cancer-specific survival rate is the percent of people with a particular diagnosis that survived until a specific time. Doctors talk about survival in a five-year time frame, but you’ll also hear one-year, two-year, and 10-year survival rates.

Survival rates can only tell you how other patients fared, not how you will fare. They also may not reflect the latest treatments, and some people live much longer than the survival statistics would suggest.

You can find cancer survival rates in the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program database. Registries like SEER typically use a three-stage approach:

  • Localized pancreatic cancers are only in and around the pancreas. This is equivalent to stage 1.
  • Regional pancreatic cancers have spread to close by lymph nodes, tissues, or organs. Usually stage 2 and 3 would fall here.
  • Distant pancreatic cancers have metastasized to remote parts of the body—this is where stage 4 cancers fall.
Pancreatic Cancer Five-Year Survival Rates
Stage  Percent of Cases at Diagnosis Five-Year Survival Rate
Localized 11% 39.4%
Regional 30% 13.3% 
Distant  52%  2.9% 
Unknown  7%  6.1%
Data from NCI’s SEER database.

Factors That Influence Survival

Cancer registries base five-year survival rates on everyone with the diagnosis—irrespective of age, health, or cancer type. Any one patient’s actual survival will dictated by other factors. Some of those factors can be changed while others can’t:

  • Age: Older patients fare worse than younger patients.
  • Race: The pancreatic cancer rate is considerably higher for Black people than any other race.
  • Cancer types: Different cells in the pancreas give rise to tumors that react differently to treatments. These include pancreatic endocrinomas, neuroendocrine tumors, small cell carcinoma, squamous cell carcinoma, adenocarcinoma, and primary pancreatic lymphoma.
  • Smoking: Tobacco use is a risk factor for developing pancreatic cancer. If no one smoked, there would be 30% fewer pancreatic cancers.
  • Alcohol: Heavy drinkers have a worse prognosis than those who don’t drink or drink less. 
  • Obesity: Excess weight before the age of 50 is correlated with increased pancreatic cancer risk.
  • Diabetes: People with diabetes have worse survival when diagnosed with pancreatic cancer.
  • Performance status: This measure of a patient’s ability to perform daily tasks is one of the best indicators of prognosis. The more trouble everyday things are, the worse off the patient is.
  • Surgery: If the doctor can cut the whole tumor out, the patient has a much better outlook.

What You Can Do

If you’ve been diagnosed with pancreatic cancer, there’s not much you can do to alter outcome based solely on lifestyle changes. Eat a healthy diet and keep active, if you can. It is possible that these types of changes can improve general health and performance status, which could lead to better outcomes, not to mention a better quality of life. 

If you’re looking to prevent pancreatic cancer (or any other negative health outcomes) it’s always a good time to quit smoking (and drinking, too!). After 10 years, your pancreatic cancer risk will be the same as a non-smoker. Sadly, if you’ve already got a diagnosis, there’s no evidence that quitting smoking actually increases survival times, though it would likely make you feel better. 

Losing weight might also sound like a good idea, and it would be if you’re trying to prevent pancreatic cancer, diabetes, and other health problems. But if you’re already diagnosed, it’s not wise to embark on a weight loss program when undergoing chemotherapy.

What you can do is make sure you’re eating the right foods and you have the right medications to help you digest food. Pancreatic cancer patients often need to be prescribed digestive enzymes to help with digestion.

Before embarking on any lifestyle intervention, speak with your oncologist.

A Word From Verywell

Pancreatic cancer is one of the toughest diagnoses someone can receive. Focus on education and being an advocate for your own care. Enlist family and friends to help you move forward. Now is the time to lean on your support network. 

Survival statistics are ever-changing. In 1977 the observed five-year relative survival rate for pancreatic cancer of any stage was 1.95%. That’s increased about 10-fold. The latest numbers, from 2012, are over 11%.

Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Pancreas cancer, SEER survival rates by time since diagnosis, 2000-2016.

  2. Khanal N, Upadhyay S, Dahal S, Bhatt VR, Silberstein PT. Systemic therapy in stage IV pancreatic cancer: a population-based analysis using the National Cancer Data BaseTher Adv Med Oncol. 2015;7(4):198-205. doi:10.1177/1758834015579313

  3. American Cancer Society. Key statistics for pancreatic cancer. Updated January 8, 2020.

  4. Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: Global trends, etiology and risk ractorsWorld J Oncol. 2019;10(1):10-27. doi:10.14740/wjon1166

  5. American Joint Committee on Cancer. What is cancer staging?

  6. American Cancer Society. Cancer staging. Updated June 18, 2020.

  7. Cancer.Net/ ASCO. Pancreatic Cancer: Stages. Updated May 2020.

  8. National Cancer Institute. Tumor grade. Updated May 3, 2013.

  9. Chang JS, Chen LT, Shan YS, Chu PY, Tsai CR, Tsai HJ. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation-wide cancer registry-based study from Taiwan. Cancer Med. 2018;7(11):5775-5788. doi:10.1002/cam4.1795

  10. Yuan C, Morales-Oyarvide V, Babic A, et. al. Cigarette smoking and pancreatic cancer survival. Journal of Clinical Oncology. 2017;35:16:1822-1828. doi:10.1200/JCO.2016.71.2026

  11. Zhang S, Wang C, Huang H. et al. Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patientsSci Rep. 2017;7,9572. doi:10.1038/s41598-017-08794-1

  12. Jacobs EJ, Newton CC, Patel AV, et. al. Abstract 3281: The association between body mass index (BMI) and risk of pancreatic cancer depends on age at BMI assessment. Cancer Res. 2019(79)(13 Supplement):3281. doi:10.1158/1538-7445.AM2019-3281

  13. Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G. Diabetes and pancreatic cancer survival: a prospective cohort-based study. Br J Cancer. 2014;111(1):181-185. doi:10.1038/bjc.2014.224

  14. Tas F, Sen F, Odabas H, Kılıc L, Keskın S, Yıldız I. Performance status of patients is the major prognostic factor at all stages of pancreatic cancer. Int J Clin Oncol. 2013 Oct;18(5):839-46. doi:10.1007/s10147-012-0474-9

  15. Yamamoto T, Yagi S, Kinoshita H, et al. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysisWorld J Gastroenterol. 2015;21(1):262-268. doi:10.3748/wjg.v21.i1.262

  16. National Cancer Institute. Pancreatic Cancer Treatment (Adult)(PDQ) — Patient Version. Updated December 11 2020.

  17. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer stat facts: Pancreatic cancer (data table).